Showing results (81-90 of 118) with videos related to
Sort By:
Pageof 12
Expert Review of Vaccines|August 22, 2022
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2Igor Age Kos, Maximilian Kiefer, Katharina Brill, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2011
Docking of lytic granules at the immunological synapse in human CTL requires Vti1b-dependent pairing with CD3 endosomesBin Qu, Varsha Pattu, Christian Junker, et al.Frontiers in Oncology|December 7, 2020
Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS LymphomaMoritz Bewarder, Maximilian Kiefer, Clara Moelle, et al.International Journal of Cancer|March 3, 2004
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitisBoris Kubuschok, Xiaoxiun Xie, Ralf Jesnowski, et al.Oncogene|April 5, 2005
Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemiaRalf Kronenwett, Ulf Butterweck, Ulrich Steidl, et al.Scientific Reports|April 26, 2024
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomasMichelle Elbert, Frank Neumann, Maximilian Kiefer, et al.Nature Cancer|January 6, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trialPaolo Strati, Lori Leslie, Parveen Shiraz, et al.Experimental Hematology|November 9, 2002
Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioningGuido Kobbe, Peter Schneider, Manuel Aivado, et al.Cancer Immunology, Immunotherapy : CII|April 18, 2020
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potentialMoritz Bewarder, Gerhard Held, Lorenz Thurner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 TrialCaron A Jacobson, Jason R Westin, David B Miklos, et al.Pageof 12